Bioretec Finland

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Johanna Salko, CFO, tel. [phone], [e-mail] 

Certified Adviser:
Nordic Certified Adviser AB, [phone]

Information about Bioretec

Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the?biological interface?of active implants?to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.?

Bioretec is?developing?the new RemeOs™?product line?based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on?value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE mark approval process is currently on-going. Bioretec is positioning itself to enter the addressable over USD 9 billion global orthopedic trauma and spine market and to become a game changer in surgical bone fracture treatment.

Better healing - Better life. www.bioretec.com 

[1] Sources:
https://www.businessresearchinsights.com/market-reports/cervical-interbody-fusion-cages-market-111868
https://www.alliedmarketresearch.com/interbody-fusion-cage-market
https://www.grandviewresearch.com/industry-analysis/spinal-fusion-device-market

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/inside-information--bioretec-updates-its-product-development-strategy-by-accelerating-the-product-de,c4047221

 

View original content:https://www.prnewswire.co.uk/news-releases/inside-information-bioretec-updates-its-product-development-strategy-by-accelerating-the-product-development-of-remeos-spinal-interbody-cage-302267690.html